Nine Masts Capital »

Revolution Medicines shares owned by Nine Masts Capital

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by Nine Masts Capital from 13F filings

Historical chart of Nine Masts Capital investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Nine Masts Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Nine Masts Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.1M 22k 97.25

More positions owned by Nine Masts Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Alphabet Cap Stk Cl C (GOOG)
Warner Bros Discovery Com Ser A (WBD)
Silicon Laboratories (SLAB)
Hdfc Bank Sponsored Ads (HDB)
Electronic Arts (EA)
Fox Corp Cl B Com (FOX)
Norfolk Southern (NSC)
Clearwater Analytics Hldgs I Cl A (CWAN)
Webster Financial Corporation (WBS)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Hologic
Nio Note 4.625%10/1 (Principal)
Ase Technology Hldg Sponsored Ads (ASX)

View all positions for Nine Masts Capital

Top funds holding Revolution Medicines

Vanguard Group
Farallon Capital Management
BlackRock
Henderson Group
Baker Bros. Advisors
FMR
Vanguard Capital Management
Nextech Invest
Vanguard Portfolio Management
Wellington Management Company
Paradigm Biocapital Advisors
Bellevue Group
UBS Group
State Street Corporation
Geode Capital Management

View all funds holding Revolution Medicines